Spring Laura

I am a Clinical Research Coordinator with the Breast Oncology Team at Massachusetts General Hospital with extensive experience in clinical research. During my first 2.5 years in this role, I was responsible for the successful management of phase I, II, and III clinical trials studying novel drug therapies in patients with early-stage and metastatic breast cancers. In February 2022, I transitioned to working on non-therapeutic projects, such as investigating the genetic mutations responsible for breast cancers that switch from estrogen receptor (ER)-positive to ER-negative. I recently first authored a review article detailing the management of metastatic triple negative breast cancer which was published in touchREVIEWS in Oncology & Haematology. I also submitted an abstract as first author for a phase I clinical trial which was selected for an oral presentation at the American Society for Radiation Oncology's Annual Meeting in October 2022. Most recently, I submitted a clinical vignette abstract on genotype-directed therapy which was accepted for a poster presentation at San Antonio Breast Cancer Symposium in December 2022. I contributed to three other abstracts as 2nd author and one abstract as 4th author, all of which will also be presented at this meeting.